---
title: "ResMed Inc. Stock Rises Monday, Outperforms Market"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/295450945.md"
description: "ResMed Inc. (RMD) shares rose 3.83% to $220.05 on Monday, outperforming the broader market which saw declines in the S&P 500 and Dow Jones Industrial Average. This gain ended a two-day losing streak for the stock. Trading volume of 1.7 million shares exceeded the 50-day average. The stock remains 25.10% below its 52-week high of $293.81 set in August."
datetime: "2026-08-10T21:00:11.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/295450945.md)
  - [en](https://longbridge.com/en/news/295450945.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/295450945.md)
generator: "portal-rs"
---

# ResMed Inc. Stock Rises Monday, Outperforms Market

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of ResMed Inc. (RMD) rallied 3.83% to $220.05 Monday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index falling 0.06% to 7,753.11 and Dow Jones Industrial Average falling 0.11% to 53,975.98.

The stock's rise snapped a two-day losing streak.

ResMed Inc. closed 25.10% short of its 52-week high of $293.81, which the company achieved on August 22nd.

Trading volume (1.7 M) eclipsed its 50-day average volume of 1.6 M.

Data source: Dow Jones Market Data, FactSet. Data compiled August 10, 2026.

This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.

(END) Dow Jones Newswires

08-10-26 1700ET

### Related Stocks

- [RMD.US](https://longbridge.com/en/quote/RMD.US.md)
- [.SPX.US](https://longbridge.com/en/quote/.SPX.US.md)
- [.DJI.US](https://longbridge.com/en/quote/.DJI.US.md)
- [FDS.US](https://longbridge.com/en/quote/FDS.US.md)
- [RMD.AU](https://longbridge.com/en/quote/RMD.AU.md)

## Related News & Research

- [Resmed Announces Appointment of Carol Burt as Lead Director and Planned Retirement of Director Ron Taylor | RMD Stock News](https://longbridge.com/en/news/296141733.md)
- [ResMed (RMD) Q4 2026 Earnings Call Transcript](https://longbridge.com/en/news/295950697.md)
- [ResMed beats on earnings and ups dividend, yet shares plummet](https://longbridge.com/en/news/295180735.md)
- [ResMed CEO Michael J. Farrell reports disposal of 4,991 common shares worth $1,026,594.05](https://longbridge.com/en/news/295521442.md)
- [ResMed director Peter C. Farrell disposes of 8,000 common shares worth $1.8 million](https://longbridge.com/en/news/295133419.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**